Cargando…
A Sox2–Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
Increased cancer stem cell content during development of resistance to tamoxifen in breast cancer is driven by multiple signals, including Sox2-dependent activation of Wnt signalling. Here, we show that Sox2 increases and estrogen reduces the expression of the transcription factor Sox9. Gain and los...
Autores principales: | Domenici, Giacomo, Aurrekoetxea-Rodríguez, Iskander, Simões, Bruno M., Rábano, Miriam, Lee, So Young, Millán, Julia San, Comaills, Valentine, Oliemuller, Erik, López-Ruiz, José A., Zabalza, Ignacio, Howard, Beatrice A., Kypta, Robert M., Vivanco, Maria dM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756022/ https://www.ncbi.nlm.nih.gov/pubmed/30622340 http://dx.doi.org/10.1038/s41388-018-0656-7 |
Ejemplares similares
-
Sox2 promotes tamoxifen resistance in breast cancer cells
por: Piva, Marco, et al.
Publicado: (2014) -
SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells
por: Oliemuller, Erik, et al.
Publicado: (2020) -
Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions
por: Iriondo, Oihana, et al.
Publicado: (2015) -
Sox9 regulates cell state and activity of embryonic mouse mammary progenitor cells
por: Kogata, Naoko, et al.
Publicado: (2018) -
The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells
por: Malhotra, Gautam K, et al.
Publicado: (2014)